EP3716968
SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
28.11.2018EP published:
31.12.2025EP application number:
18884002.9
EPO information:
European Patent Register
Max expiry date:
27.11.2038Expiry date:
27.11.2026
Title in English:
SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPYLanguage of the patent:
English
Timeline
Today
28.11.2018EP application
31.12.2025EP Publication
27.11.2026Expires
Owner
Name:
Anavex Life Sciences Corp.Address:
51 West 52nd Street 7th Floor, New York, NY 10019, US
Inventor
Name:
MISSLING, Christopher, U.Address:
New York NY 10019, US
Priority
Number:
201762591248 PDate:
28.11.2017Country:
US
Classification
Categories:
A61K 31/341, A61K 31/13, A61K 31/138, A61K 31/404, C07D 307/14, A61K 45/06, A61P 9/12